Artigos | 11 de novembro de 2021 A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial Continue lendo
Artigos | 11 de novembro de 2021 Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial Continue lendo
Artigos | 9 de novembro de 2021 Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve Continue lendo
Artigos | 9 de novembro de 2021 Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial Continue lendo
Artigos | 9 de novembro de 2021 Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial Continue lendo
Artigos | 9 de novembro de 2021 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 Continue lendo
Artigos | 9 de novembro de 2021 Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission Continue lendo
